1,152 material Form 8-K filings that 918 companies we cover made with the SEC in October 2025, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
Solventum appointed Heather Knight to a newly created Chief Commercial Officer role, effective November 10, 2025, where she will oversee global commercial and R&D operations across its MedSurg, Dental Solutions and Health Information Systems segments. Chris Barry, Executive Vice President and Group President of MedSurg, will leave the company effective December 31, 2025, and may receive severance if he signs a general release. The filing gives no financial impact figures, but the leadership change restructures commercial oversight for shareholders.
Heather Knight becomes Chief Commercial Officer effective November 10, 2025, reporting directly to CEO Bryan Hanson
Knight previously served as Chief Operating Officer at Baxter International and has over 30 years of MedTech experience
Chris Barry, EVP and Group President of MedSurg, departs effective December 31, 2025
Barry may receive severance under the Solventum Executive Severance Plan, subject to a signed general release
Fluor said Group President Project Execution Mark E. Fields intends to retire in 2026 and will take the role of Group President, Strategic Projects, effective November 1, 2025, as part of succession planning. Michael E. Alexander and Pierre Bechelany will take over the Project Execution and Energy Solutions roles on the same date. The filing describes an internal reshuffle of senior operating roles and does not report any financial results or guidance changes.
Mark E. Fields notified Fluor on October 17, 2025 that he intends to retire in 2026
Fields moves to Group President, Strategic Projects, effective November 1, 2025
Michael E. Alexander moves to Group President, Project Execution, effective November 1, 2025
Pierre Bechelany moves to Business Group President, Energy Solutions, effective November 1, 2025
Iron Mountain's board elected Christie Kelly, a former chief financial officer of several real estate companies, as a director effective October 21, 2025. She joins the Audit Committee and will receive director compensation, including a prorated grant of restricted stock units that vest immediately. The change adds a board member with finance experience but does not alter company operations or results.
Christie Kelly, age 64, elected to the board effective October 21, 2025, and assigned to the Audit Committee.
Prior roles include EVP, CFO and Treasurer of Realty Income Corporation (2021 to 2023) and EVP and Global CFO of Jones Lang LaSalle (2013 to 2018).
She will receive a prorated annual grant of RSUs under the Director Compensation Plan, each representing one share of common stock, vesting immediately upon grant.
Atlas Energy Solutions said Chris Scholla, EVP and President of Sand and Logistics, is leaving the company effective October 21, 2025. CEO John Turner will lead the sand and logistics operations while the company searches for a successor, and Scholla's departure is treated as a qualifying termination under the company's change-in-control severance plan.
Chris Scholla's departure as EVP and President, Sand and Logistics is effective October 21, 2025
The departure is a Qualifying Termination under the Management Change in Control Severance Plan
Severance benefits are subject to a participant agreement and general release
John Turner, President and CEO, will lead sand and logistics operations until a successor is named
Flowers Foods said D. Anthony Scaglione, former CFO of ODP Corporation and ABM Industries, will become chief financial officer effective January 1, 2026, succeeding Steve Kinsey, who will retire at year-end. The filing sets his base salary at $785,000 and a special equity award with a targeted grant date value of $1,400,000, which matters to shareholders as a planned change in the company's top finance role.
Appointment effective January 1, 2026; Scaglione succeeds Steve Kinsey, who retires at year-end and will serve in an advisory role for a period
Initial base salary of $785,000 annually; annual bonus target of 100% of base salary and long-term incentive target of 210% of base salary, beginning fiscal 2026
Special time-based restricted stude award with a targeted grant date value of $1,400,000, plus a $50,000 cash payment on his first day of employment
Scaglione is expected to relocate near the Thomasville, Georgia offices no later than August 31, 2026
Baxter International said Executive Vice President and Chief Operating Officer Heather Knight will resign effective October 29, 2025, to join a healthcare company, and she also leaves her interim role leading Medical Products and Therapies. CEO Andrew Hider will take over that interim group president role, and the company will have no COO after the transition date. The filing gives no financial figures, but the loss of a COO and the added duties for the CEO are leadership changes shareholders may want to watch.
Heather Knight resigns as EVP and COO, effective October 29, 2025, to join a healthcare industry company
Knight also steps down as interim group president of Medical Products and Therapies on the same date
CEO Andrew Hider will assume the interim MPT group president role
After October 29, 2025, Baxter will no longer have a chief operating officer
Jabil said Executive Chairman Mark T. Mondello and directors Kathleen A. Walters and James Siminoff will not seek re-election, with their terms ending at the 2026 Annual Meeting on January 22, 2026. Lead Director Steven Raymund is expected to become board chairman, and the board will shrink to seven members before that meeting, which changes board leadership but reports no financial results.
Mondello, Walters and Siminoff will remain on the board until the 2026 Annual Meeting, with terms concluding January 22, 2026
Lead Director Steven Raymund is expected to assume the role of chairman when Mondello departs
Jabil anticipates a consulting agreement with Mondello effective at the time of his departure
The board approved reducing its size to seven members, effective immediately before the 2026 Annual Meeting
Pentair announced that Robert Fishman, its Executive Vice President and Chief Financial Officer, will resign effective March 1, 2026, and that Nicholas J. Brazis, currently Vice President, Corporate Development and Treasury, will succeed him as Executive Vice President and Chief Financial Officer on the same date. The company also elevated Heather Hausmann to an Executive Vice President role reporting directly to the CEO, which changes the reporting line for her technology leadership.
Robert P. Fishman resigns as EVP and CFO effective March 1, 2026; his resignation entitles him to severance under the Executive Officer Severance Plan, subject to its conditions
Nicholas J. Brazis, 45, appointed EVP and CFO effective March 1, 2026, and Senior Vice President, Finance effective November 1, 2025
Heather Hausmann's role is elevated to EVP, Chief Information Officer and Chief Information Security Officer, reporting directly to the CEO
Compensation for Mr. Brazis as CFO has not yet been determined by the Compensation Committee
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.